Detalles de la búsqueda
1.
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.
JCO Glob Oncol
; 10: e2300484, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38603658
2.
Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience.
Oncologist
; 18(2): 134-40, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359433
3.
Breast cancer in Brazil: present status and future goals.
Lancet Oncol
; 13(3): e95-e102, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22381937
4.
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective.
Ther Adv Med Oncol
; 14: 17588359221100865, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36339925
5.
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE.
J Clin Oncol
; 39(1): 79-89, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822287
6.
Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer.
Rev Assoc Med Bras (1992)
; 56(1): 22-6, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20339781
7.
Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting.
Chin Clin Oncol
; 9(5): 61, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32819114
8.
Cross-Cultural Validity Study of a Medical Education Leadership Competencies Instrument in Latin American Physicians: A Multinational Study.
J Glob Oncol
; 5: 1-9, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770067
9.
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE.
J Clin Oncol
; 36(8): 741-748, 2018 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244528
10.
The germline mutational landscape of BRCA1 and BRCA2 in Brazil.
Sci Rep
; 8(1): 9188, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29907814
11.
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
J Clin Oncol
; 35(13): 1421-1429, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28375706
12.
Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer.
Oncogene
; 23(39): 6684-92, 2004 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-15221013
13.
Case studies of fulvestrant ("Faslodex") in postmenopausal women with advanced breast cancer.
Cancer Treat Rev
; 31 Suppl 2: S17-25, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16199128
14.
Fulvestrant ("Faslodex"): clinical experience from the Compassionate Use Programme.
Cancer Treat Rev
; 31 Suppl 2: S10-6, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16198057
15.
Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine.
Int J Gastrointest Cancer
; 32(1): 35-41, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12630768
16.
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.
Cancer Epidemiol Biomarkers Prev
; 23(1): 126-33, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24165578
17.
Cetuximab Plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan: the LABEL study.
Clin Colorectal Cancer
; 9(5): 282-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21208842
18.
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
Artículo
en Inglés
| ARCA | ID: arc-28925
19.
Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer / Evidência adicional do papel prognóstico do nível pré-tratamento de CA 19-9 em câncer de pâncreas avançado
Rev. Assoc. Med. Bras. (1992)
; 56(1): 22-26, 2010. tab, ilus
Artículo
en Inglés
| LILACS | ID: lil-541157
20.
Inibidores da aromatase no cncer de mama: da doena metast tica ao tratamento adjuvante / Aromatase inhibitors in breast cancer: from metastatic disease to adjuvant treatment
Rev. bras. cancerol
; 48(4): 555-567, out.-dez. 2002. tab
Artículo
en Portugués
| TXTC | ID: txt-21280